David C. Soler,Andrew E. Sloan,Kevin D. Cooper,Thomas S. McCormick,Andrew B. Young
申请号：
US15663325
公开号：
US10066020B2
申请日:
2017.07.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A method of detecting the presence of glioblastomas and/or recurrent glioblastomas in a subject in need thereof includes isolating CD14+ cells from a blood sample of the subject and determining the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2, wherein the subject has increased risk of glioblastomas or recurrent glioblastoma if the ratio of isolated CD14+ cells expressing low levels of HLA-DR to isolated CD14+ cells expressing VNN2 is greater than about 2.
